Stepan Reports Third Quarter 2024 Results
Third Quarter 2024 Highlights
- Reported net income was
$23.6 million , up 88% versus prior year. Adjusted net income(1) was$23.7 million , up 61% versus prior year, largely due to higher margins and a lower effective tax rate. The year-over-year change in effective tax rate positively impacted net income by$6.8 million , or$0.30 per diluted share. - EBITDA(2) was
$53.0 million and Adjusted EBITDA(2) was$53.1 million , up 18% and 11% respectively, year-over-year. - Global sales volume was down 1% year-over-year. Double digit growth in several Surfactant end markets was fully offset by demand weakness in Polymers.
- Cash from Operations was
$22.7 million during the quarter. Free cash flow(3) for the quarter was a negative$4.0 million . - The Company is on track to deliver its
$50 million cost out goal for 2024 and recognized$13.3 million in pre-tax savings in the third quarter.
YTD 2024 Highlights
- Reported net income was
$47.0 million , up 14% versus prior year. Adjusted net income(1) was$47.7 million , up 10% year-over-year. - EBITDA(2) was
$151.0 million and Adjusted EBITDA(2) was$151.9 million , up 8% and 7% respectively, year-over-year. - Global sales volume was up 1% year-over-year.
"Team Stepan delivered a solid quarter despite significant challenges. Third quarter adjusted EBITDA grew double digits driven by the Surfactant and Specialty Product businesses. Surfactants continued its volume recovery and experienced double-digit volume growth within the Agricultural, Oilfield and the Construction and Industrial Solutions end markets and also with our Distribution partners. Latin America Surfactant volume grew mid-single digits driven by strong demand within the Agricultural end markets in
Financial Summary
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands, except per share data) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
|
$ |
546,842 |
$ |
562,226 |
(3) |
% |
$ |
1,654,665 |
$ |
1,793,637 |
(8) |
% |
||||||||||||
Operating Income |
$ |
23,949 |
$ |
19,517 |
23 |
% |
$ |
62,785 |
$ |
58,383 |
8 |
% |
||||||||||||
Net Income |
$ |
23,606 |
$ |
12,571 |
88 |
% |
$ |
47,020 |
$ |
41,397 |
14 |
% |
||||||||||||
Earnings per Diluted Share |
$ |
1.03 |
$ |
0.55 |
87 |
% |
$ |
2.05 |
$ |
1.80 |
14 |
% |
||||||||||||
Adjusted Net Income * |
$ |
23,661 |
$ |
14,730 |
61 |
% |
$ |
47,713 |
$ |
43,206 |
10 |
% |
||||||||||||
Adjusted Earnings per |
$ |
1.03 |
$ |
0.64 |
61 |
% |
$ |
2.08 |
$ |
1.88 |
11 |
% |
* See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share. |
Percentage Change in
Net sales in the third quarter of 2024 decreased 3% year-over-year. The decline in net sales was impacted equally by a 1% drop in volume, lower selling prices and foreign currency translation.
Three Months Ended |
Nine Months Ended |
|||||||
Volume |
(1) |
% |
1 |
% |
||||
Selling Price & Mix |
(1) |
% |
(9) |
% |
||||
Foreign Translation |
(1) |
% |
(—) |
% |
||||
Total |
(3) |
% |
(8) |
% |
Segment Results
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
|
||||||||||||||||||||||||
Surfactants |
$ |
382,724 |
$ |
373,836 |
2 |
% |
$ |
1,153,339 |
$ |
1,233,351 |
(6) |
% |
||||||||||||
Polymers |
$ |
149,796 |
$ |
169,559 |
(12) |
% |
$ |
455,061 |
$ |
495,200 |
(8) |
% |
||||||||||||
Specialty Products |
$ |
14,322 |
$ |
18,831 |
(24) |
% |
$ |
46,265 |
$ |
65,086 |
(29) |
% |
||||||||||||
Total |
$ |
546,842 |
$ |
562,226 |
(3) |
% |
$ |
1,654,665 |
$ |
1,793,637 |
(8) |
% |
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands, all amounts pre-tax) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
Operating Income |
||||||||||||||||||||||||
Surfactants |
$ |
26,303 |
$ |
15,373 |
71 |
% |
$ |
69,445 |
$ |
57,570 |
21 |
% |
||||||||||||
Polymers |
$ |
15,248 |
$ |
21,813 |
(30) |
% |
$ |
37,227 |
$ |
48,137 |
(23) |
% |
||||||||||||
Specialty Products |
$ |
3,727 |
$ |
2,402 |
55 |
% |
$ |
15,314 |
$ |
8,704 |
76 |
% |
||||||||||||
Total Segment |
$ |
45,278 |
$ |
39,588 |
14 |
% |
$ |
121,986 |
$ |
114,411 |
7 |
% |
||||||||||||
Corporate Expenses |
$ |
(21,329) |
$ |
(20,071) |
6 |
% |
$ |
(59,201) |
$ |
(56,028) |
6 |
% |
||||||||||||
Consolidated |
$ |
23,949 |
$ |
19,517 |
23 |
% |
$ |
62,785 |
$ |
58,383 |
8 |
% |
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in millions) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
EBITDA |
$ |
53.0 |
$ |
45.1 |
18 |
% |
$ |
151.0 |
$ |
140.1 |
8 |
% |
||||||||||||
Adjusted EBITDA |
||||||||||||||||||||||||
Surfactants |
$ |
44.2 |
$ |
31.6 |
40 |
% |
$ |
122.9 |
$ |
105.1 |
17 |
% |
||||||||||||
Polymers |
$ |
23.4 |
$ |
29.7 |
(21) |
% |
$ |
61.6 |
$ |
72.6 |
(15) |
% |
||||||||||||
Specialty Products |
$ |
5.2 |
$ |
3.9 |
33 |
% |
$ |
19.8 |
$ |
13.0 |
52 |
% |
||||||||||||
Unallocated Corporate |
$ |
(19.7) |
$ |
(17.2) |
15 |
% |
$ |
(52.4) |
$ |
(48.2) |
9 |
% |
||||||||||||
Consolidated Adjusted EBITDA |
$ |
53.1 |
$ |
48.0 |
11 |
% |
$ |
151.9 |
$ |
142.5 |
7 |
% |
Consolidated operating income increased
- Surfactant net sales were
$382.7 million for the quarter, a 2% increase versus the prior year. Selling prices were up 1% primarily due to improved product and customer mix. Sales volume was up 3% year-over-year primarily due to double digit growth within the Agricultural, Oilfield and the Construction and Industrial Solutions end markets along with our distribution partners. This growth was partially offset by lower demand within the Consumer Products end markets. Foreign currency translation negatively impacted net sales by 2%. Surfactant operating income for the quarter increased$10.9 million , or 71%, versus the prior year. Surfactant adjusted EBITDA(2) increased$12.6 million , or 40%, versus the prior year. This increase was primarily driven by the 3% growth in sales volume and margin improvement that was partially offset by pre-operating expenses at the Company's new alkoxylation facility being built inPasadena, Texas . - Polymer net sales were
$149.8 million for the quarter, a 12% decrease versus the prior year. Selling prices decreased 3%, primarily due to the pass-through of lower raw material costs and competitive pressures. Sales volume declined 11% in the quarter primarily due to a 13% decrease in global Rigid Polyols demand and a 27% decrease in commodity Phthalic Anhydride volume. Specialty Polyols volume was up year-over-year. Foreign currency translation positively impacted net sales by 2%. Polymer operating income decreased$6.6 million , or 30%, versus the prior year. Polymer adjusted EBITDA(2) decreased$6.3 million , or 21%, versus the prior year primarily due to the 11% decline in sales volume. - Specialty Product net sales were
$14.3 million for the quarter, a 24% decrease versus the prior year, primarily due to lower selling prices. Sales volume was down 5% versus the prior year. Specialty Product operating income increased$1.3 million , or 55%, versus the prior year. Specialty Product adjusted EBITDA(2) increased$1.3 million , or 33%. The increase in adjusted EBITDA(2) was primarily due to higher unit margins within the medium chain triglycerides product line.
Income Taxes
The Company's effective tax rate was a negative 10.7% during the third quarter of 2024 versus 20.6% in the third quarter of 2023. The decrease was primarily attributable to the Company's intention to make an election under the
Outlook
"Team Stepan continues to be focused on executing our strategic growth projects. We are pleased that several of our Surfactant businesses continue to deliver strong volume growth. Agricultural volumes grew double-digits in the third quarter which aligns with our expectations for a second half 2024 recovery. We remain optimistic Rigid Polyol demand will increase as the market gets more macro-economic clarity and the interest rate environment improves," said
Notes |
(1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, cash-settled stock appreciation rights (SARs) income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share. |
(2) EBITDA and adjusted EBITDA are non-GAAP measures. See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA. |
(3) Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures. Cash generated from operations was |
Conference Call
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.
Corporate Profile
Headquartered in
The Company's common stock is traded on the
More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about
There are a number of risks, uncertainties and other important factors, many of which are beyond
These forward-looking statements are made only as of the date hereof, and
Tables follow
Table I |
||||||||||||||||
|
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
|
$ |
546,842 |
$ |
562,226 |
$ |
1,654,665 |
$ |
1,793,637 |
||||||||
Cost of Sales |
471,157 |
490,990 |
1,439,147 |
1,582,444 |
||||||||||||
Gross Profit |
75,685 |
71,236 |
215,518 |
211,193 |
||||||||||||
Operating Expenses: |
||||||||||||||||
Selling |
11,394 |
11,811 |
34,610 |
35,987 |
||||||||||||
Administrative |
26,254 |
22,904 |
73,513 |
68,132 |
||||||||||||
Research, Development and Technical Services |
13,532 |
14,477 |
41,881 |
43,720 |
||||||||||||
Deferred Compensation Expense |
556 |
(3,101) |
2,729 |
(856) |
||||||||||||
51,736 |
46,091 |
152,733 |
146,983 |
|||||||||||||
Business Restructuring Expense |
- |
5,628 |
- |
5,827 |
||||||||||||
Operating Income |
23,949 |
19,517 |
62,785 |
58,383 |
||||||||||||
Other Income (Expense): |
||||||||||||||||
Interest, Net |
(3,621) |
(2,987) |
(9,353) |
(9,674) |
||||||||||||
Other, Net |
989 |
(690) |
4,551 |
3,348 |
||||||||||||
(2,632) |
(3,677) |
(4,802) |
(6,326) |
|||||||||||||
Income Before Provision for Income Taxes |
21,317 |
15,840 |
57,983 |
52,057 |
||||||||||||
Provision for Income Taxes |
(2,289) |
3,269 |
10,963 |
10,660 |
||||||||||||
Net Income |
23,606 |
12,571 |
47,020 |
41,397 |
||||||||||||
Net Income Per Common Share |
||||||||||||||||
Basic |
$ |
1.03 |
$ |
0.55 |
$ |
2.06 |
$ |
1.82 |
||||||||
Diluted |
$ |
1.03 |
$ |
0.55 |
$ |
2.05 |
$ |
1.80 |
||||||||
Shares Used to Compute Net Income Per |
||||||||||||||||
Basic |
22,836 |
22,786 |
22,829 |
22,770 |
||||||||||||
Diluted |
22,923 |
22,930 |
22,936 |
22,956 |
Table II |
||||||||||||||||||||||||||||||||
Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share* |
||||||||||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2024 |
EPS |
2023 |
EPS |
2024 |
EPS |
2023 |
EPS |
||||||||||||||||||||||||
Net Income Reported |
$ |
23,606 |
$ |
1.03 |
$ |
12,571 |
$ |
0.55 |
$ |
47,020 |
$ |
2.05 |
$ |
41,397 |
$ |
1.80 |
||||||||||||||||
Deferred Compensation |
$ |
(350) |
$ |
(0.02) |
$ |
(2,038) |
$ |
(0.09) |
$ |
(1,043) |
$ |
(0.05) |
$ |
(2,795) |
$ |
(0.12) |
||||||||||||||||
Business Restructuring Expense |
$ |
- |
$ |
- |
$ |
4,219 |
$ |
0.18 |
$ |
- |
$ |
- |
$ |
4,365 |
$ |
0.19 |
||||||||||||||||
Cash-Settled SARs Income |
$ |
- |
$ |
- |
$ |
(61) |
$ |
- |
$ |
- |
$ |
- |
$ |
(145) |
$ |
(0.01) |
||||||||||||||||
Environmental Remediation |
$ |
405 |
$ |
0.02 |
$ |
39 |
$ |
- |
$ |
1,736 |
$ |
0.08 |
$ |
384 |
$ |
0.02 |
||||||||||||||||
Adjusted Net Income |
$ |
23,661 |
$ |
1.03 |
$ |
14,730 |
$ |
0.64 |
$ |
47,713 |
$ |
2.08 |
$ |
43,206 |
$ |
1.88 |
* All amounts in this table are presented after-tax |
The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition. The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators. Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years. These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies. The Company's Annual Report on Form 10-K for the year ended
Summary of Third Quarter 2024 Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense, cash-settled SARs income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.
- Deferred Compensation: The third quarter of 2024 reported net income includes
$0.4 million of after-tax income versus$2.0 million of after-tax income in the prior year. - Environmental Remediation: The third quarter of 2024 reported net income includes
$0.4 million of after-tax expense versus less than$0.1 million of after-tax expense in the prior year.
Table III |
||||||||||||||||||||||||||||||||
Reconciliation of Pre-Tax to After-Tax Adjustments |
||||||||||||||||||||||||||||||||
Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the transactions occurred. |
||||||||||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2024 |
EPS |
2023 |
EPS |
2024 |
EPS |
2023 |
EPS |
||||||||||||||||||||||||
Pre-Tax Adjustments |
||||||||||||||||||||||||||||||||
Deferred Compensation |
$ |
(466) |
$ |
(2,717) |
$ |
(1,390) |
$ |
(3,726) |
||||||||||||||||||||||||
Business Restructuring Expense |
$ |
- |
$ |
5,628 |
$ |
- |
$ |
5,827 |
||||||||||||||||||||||||
Cash-Settled SARs Income |
$ |
- |
$ |
(82) |
$ |
- |
$ |
(193) |
||||||||||||||||||||||||
Environmental Remediation |
$ |
541 |
$ |
52 |
$ |
2,315 |
$ |
513 |
||||||||||||||||||||||||
Total Pre-Tax Adjustments |
$ |
75 |
$ |
2,881 |
$ |
925 |
$ |
2,421 |
||||||||||||||||||||||||
Cumulative Tax Effect |
$ |
(20) |
$ |
(722) |
$ |
(232) |
$ |
(612) |
||||||||||||||||||||||||
After-Tax Adjustments |
$ |
55 |
$ |
- |
$ |
2,159 |
$ |
0.09 |
$ |
693 |
$ |
0.03 |
$ |
1,809 |
$ |
0.08 |
||||||||||||||||
Table IV |
||||||||||||||||||||||||||||
Deferred Compensation Plans |
||||||||||||||||||||||||||||
The full effect of the deferred compensation plans on quarterly pre-tax income was |
||||||||||||||||||||||||||||
2024 |
2023 |
|||||||||||||||||||||||||||
9/30 |
6/30 |
3/31 |
12/31 |
9/30 |
6/30 |
3/31 |
||||||||||||||||||||||
|
$ |
77.25 |
$ |
83.96 |
$ |
90.04 |
$ |
94.55 |
$ |
74.97 |
$ |
95.56 |
$ |
103.03 |
||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
($ in thousands) |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Deferred Compensation |
||||||||||||||||
Operating Income (Expense) |
$ |
(556) |
$ |
3,101 |
$ |
(2,729) |
$ |
856 |
||||||||
Other, net – Mutual Fund Gain (Loss) |
1,022 |
(384) |
4,119 |
2,870 |
||||||||||||
Total Pre-Tax |
$ |
466 |
$ |
2,717 |
$ |
1,390 |
$ |
3,726 |
||||||||
Total After-Tax |
$ |
350 |
$ |
2,038 |
$ |
1,043 |
$ |
2,795 |
Effects of Foreign Currency Translation |
||||||||||||||||||||||||||||||||
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into |
||||||||||||||||||||||||||||||||
($ in millions) |
Three Months Ended |
Change |
Change |
Nine Months Ended |
Change |
Change |
||||||||||||||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||||||||||||||||||
|
$ |
546.8 |
$ |
562.2 |
$ |
(15.4) |
$ |
(5.6) |
$ |
1,654.7 |
$ |
1,793.6 |
$ |
(138.9) |
$ |
7.0 |
||||||||||||||||
Gross Profit |
75.7 |
71.2 |
$ |
4.5 |
(0.9) |
215.5 |
211.2 |
$ |
4.3 |
0.1 |
||||||||||||||||||||||
Operating Income |
23.9 |
19.5 |
$ |
4.4 |
(0.4) |
62.8 |
58.4 |
$ |
4.4 |
0.2 |
||||||||||||||||||||||
Pretax Income |
21.3 |
15.8 |
$ |
5.5 |
(0.5) |
58.0 |
52.1 |
$ |
5.9 |
0.0 |
Corporate Expenses |
||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2024 |
2023 |
% |
2024 |
2023 |
% |
||||||||||||||||||
Total Corporate Expenses |
$ |
21,329 |
$ |
20,071 |
6 |
% |
$ |
59,201 |
$ |
56,028 |
6 |
% |
||||||||||||
Less: |
||||||||||||||||||||||||
Deferred Compensation (Income) Expense |
$ |
556 |
$ |
(3,101) |
NM |
$ |
2,729 |
$ |
(856) |
NM |
||||||||||||||
Business Restructuring Expense |
$ |
- |
$ |
5,628 |
NM |
$ |
- |
$ |
5,827 |
NM |
||||||||||||||
Environmental Remediation |
$ |
541 |
$ |
52 |
NM |
$ |
2,315 |
$ |
513 |
NM |
||||||||||||||
Adjusted Corporate Expenses |
$ |
20,232 |
$ |
17,492 |
16 |
% |
$ |
54,157 |
$ |
50,544 |
7 |
% |
Adjusted Corporate expenses increased
Table V |
||||||||
|
||||||||
|
|
|||||||
ASSETS |
||||||||
Current Assets |
$ |
918,158 |
$ |
851,883 |
||||
Property, Plant & Equipment, Net |
1,201,946 |
1,206,665 |
||||||
Other Assets |
293,685 |
304,806 |
||||||
Total Assets |
$ |
2,413,789 |
$ |
2,363,354 |
||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||
Current Liabilities |
$ |
721,293 |
$ |
607,870 |
||||
Deferred Income Taxes |
10,676 |
10,373 |
||||||
Long-term Debt |
348,670 |
401,248 |
||||||
Other Non-current Liabilities |
113,785 |
127,373 |
||||||
Total Stepan Company Stockholders' Equity |
1,219,365 |
1,216,490 |
||||||
Total Liabilities and Stockholders' Equity |
$ |
2,413,789 |
$ |
2,363,354 |
Selected Balance Sheet Information |
|||||||||||||||
The Company's total debt increased by |
|||||||||||||||
($ in millions) |
|
|
|
|
|||||||||||
Net Debt |
|||||||||||||||
Total Debt |
$ |
688.5 |
$ |
657.1 |
$ |
646.0 |
$ |
654.1 |
|||||||
Cash |
147.3 |
124.7 |
125.8 |
129.8 |
|||||||||||
Net Debt |
$ |
541.2 |
$ |
532.4 |
$ |
520.2 |
$ |
524.3 |
|||||||
Equity |
1,219.4 |
1,192.4 |
1,214.5 |
1,216.5 |
|||||||||||
Net Debt + Equity |
$ |
1,760.6 |
$ |
1,724.8 |
$ |
1,734.7 |
$ |
1,740.8 |
|||||||
Net Debt / (Net Debt + Equity) |
31 |
% |
31 |
% |
30 |
% |
30 |
% |
The major working capital components were: |
($ in millions) |
|
|
|
|
|||||||||||
Net Receivables |
$ |
434.1 |
$ |
437.3 |
$ |
446.6 |
$ |
422.1 |
|||||||
Inventories |
296.7 |
266.0 |
257.1 |
265.6 |
|||||||||||
Accounts Payable |
(257.1) |
(251.2) |
(256.9) |
(233.0) |
|||||||||||
$ |
473.7 |
$ |
452.1 |
$ |
446.8 |
$ |
454.7 |
Table VI |
||||||||||||||||||||
Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA |
||||||||||||||||||||
Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. Refer to the Income Statement on Table I for a bridge between Operating Income and Net Income. |
||||||||||||||||||||
Three Months Ended |
||||||||||||||||||||
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
Operating Income |
$ |
26.3 |
$ |
15.2 |
$ |
3.7 |
$ |
(21.3) |
$ |
23.9 |
||||||||||
Depreciation and Amortization |
$ |
17.9 |
$ |
8.2 |
$ |
1.5 |
$ |
0.5 |
$ |
28.1 |
||||||||||
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
1.0 |
$ |
1.0 |
||||||||||
EBITDA |
$ |
53.0 |
||||||||||||||||||
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.4) |
$ |
(0.4) |
||||||||||
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.5 |
$ |
0.5 |
||||||||||
Adjusted EBITDA |
$ |
44.2 |
$ |
23.4 |
$ |
5.2 |
$ |
(19.7) |
$ |
53.1 |
||||||||||
Three Months Ended |
||||||||||||||||||||
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
Operating Income |
$ |
15.4 |
$ |
21.8 |
$ |
2.4 |
$ |
(20.1) |
$ |
19.5 |
||||||||||
Depreciation and Amortization |
$ |
16.3 |
$ |
7.9 |
$ |
1.5 |
$ |
0.6 |
$ |
26.3 |
||||||||||
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.7) |
$ |
(0.7) |
||||||||||
EBITDA |
$ |
45.1 |
||||||||||||||||||
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(2.7) |
$ |
(2.7) |
||||||||||
Cash Settled SARs |
$ |
(0.1) |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.1) |
||||||||||
Business Restructuring |
$ |
- |
$ |
- |
$ |
- |
$ |
5.6 |
$ |
5.6 |
||||||||||
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.1 |
$ |
0.1 |
||||||||||
Adjusted EBITDA |
$ |
31.6 |
$ |
29.7 |
$ |
3.9 |
$ |
(17.2) |
$ |
48.0 |
||||||||||
Nine Months Ended |
||||||||||||||||||||
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
Operating Income |
$ |
69.4 |
$ |
37.2 |
$ |
15.3 |
$ |
(59.2) |
$ |
62.7 |
||||||||||
Depreciation and Amortization |
$ |
53.5 |
$ |
24.4 |
$ |
4.5 |
$ |
1.3 |
$ |
83.7 |
||||||||||
Other, Net Income |
$ |
- |
$ |
- |
$ |
- |
$ |
4.6 |
$ |
4.6 |
||||||||||
EBITDA |
$ |
151.0 |
||||||||||||||||||
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(1.4) |
$ |
(1.4) |
||||||||||
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
2.3 |
$ |
2.3 |
||||||||||
Adjusted EBITDA |
$ |
122.9 |
$ |
61.6 |
$ |
19.8 |
$ |
(52.4) |
$ |
151.9 |
||||||||||
Nine Months Ended |
||||||||||||||||||||
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
Operating Income |
$ |
57.6 |
$ |
48.1 |
$ |
8.7 |
$ |
(56.0) |
$ |
58.4 |
||||||||||
Depreciation and Amortization |
$ |
47.7 |
$ |
24.5 |
$ |
4.3 |
$ |
1.9 |
$ |
78.4 |
||||||||||
Other, Net Income (Expense) |
$ |
- |
$ |
- |
$ |
- |
$ |
3.3 |
$ |
3.3 |
||||||||||
EBITDA |
$ |
140.1 |
||||||||||||||||||
Deferred Compensation |
$ |
- |
$ |
- |
$ |
- |
$ |
(3.7) |
$ |
(3.7) |
||||||||||
Cash Settled SARs |
$ |
(0.2) |
$ |
- |
$ |
- |
$ |
- |
$ |
(0.2) |
||||||||||
Business Restructuring |
$ |
- |
$ |
- |
$ |
- |
$ |
5.8 |
$ |
5.8 |
||||||||||
Environmental Remediation |
$ |
- |
$ |
- |
$ |
- |
$ |
0.5 |
$ |
0.5 |
||||||||||
Adjusted EBITDA |
$ |
105.1 |
$ |
72.6 |
$ |
13.0 |
$ |
(48.2) |
$ |
142.5 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-third-quarter-2024-results-302291240.html
SOURCE
Luis E. Rojo 847-446-7500